The Autumn 1998 issue of the NPF Parkinson Report has
an article on Mitochondrial COQ-10.They describe on-going studies
evaluating benefits to PD patients;so far unproven.
Potential benefits are based on COQ-10's dual roles in
mitochondrial function and as an anti-oxidant since PD patients have both
mitochondrial dysfunction and damage to nerve cells in the substantia nigra
due to oxidative free radicals.
I have a file entitled:
INTRODUCTION TO COENZYME Q10
By PETER H. LANGSJOEN, M.D., F.A.C.C.
which I can send to anyone interested.Since it is longer
than 500 lines it can't be sent on this list.Benefits are
cited for people with heart disease.
Gil,CG for Aliza
------------------------------
Date: Sun, 7 Mar 1999 06:53:41 -0600
From: Linda Potter <[log in to unmask]>
Subject: Re: Coenzyme Q-ten?
On Sat, 6 Mar 1999 20:42:57 EST John Gooch <[log in to unmask]> writes:
>Does anyone want to say anything or any praises for this?
>I am still trying to find out what it is and how it works for PD.
>
John - Of course I can't find my reference on coenzyme Q10 now, but
basically it is an antioxidant which is supposed to rid the body ( brain
) of free radicals , which destroy our dopamine source, the substantia
nigra. I hope I got it right. Linda
-----------
Date: Sun, 7 Mar 1999 09:18:09 -0500
From: MR JOSEPH GIBBONS <[log in to unmask]>
Subject: co-enzyme Q-10
John--Look in the archives for 1/21/99. There will be a 3-year study
to determine if Co-enzyme Q-10 is neuroprotective. Dosages will be
300, 600, or 1,200 milligrams per day. The archive address is
http://james.parkinsons.org.uk/index.htm.
Ann Gibbons
------------------------------
